Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by C. Streuper
The First Experiences With Reassessments and Appraisals of Conditionally Approved Expensive and Orphan Drugs in the Netherlands (2006-2013)
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Related publications
Reimbursement of Orphan Drugs: The Pompe and Fabry Case in the Netherlands
Orphanet Journal of Rare Diseases
Medicine
Genetics
Pharmacology
Pivotal Studies of Orphan Drugs Approved for Neurological Diseases
Annals of Neurology
Neurology
Analysis of the Ultra-Orphan Drugs Approved by the Fda in the Period 1983-2014
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Php239 - The Introduction and Implications of the Cost-Containment Measure ‘The Sluice’ for Expensive Innovative Drugs in the Netherlands
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Comparison of Recent Hta Appraisals of Orphan Drugs by Nice, SMC and Has in 2015-2017
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Managed Entry Agreements and Orphan Drugs: A European Comparative Study (2006-2012)
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
First International South Caucasian Conference on Rare Diseases and Orphan Drugs
European Journal of Pediatrics
Child Health
Pediatrics
Perinatology
Medical Paternalism and Expensive Unsubsidised Drugs
BMJ
Examining the Target Population of Orphan Drugs: Are Drugs Exceeding the Intended Purposes of the Orphan Drug Act?
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental